Literature DB >> 22960662

PharmGKB summary: zidovudine pathway.

Yogita Ghodke1, Peter L Anderson, Katrin Sangkuhl, Jatinder Lamba, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22960662      PMCID： PMC3696524          DOI： 10.1097/FPC.0b013e32835879a8

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  30 in total

1.  Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Authors:  David Nolan; Emma Hammond; Annalise Martin; Louise Taylor; Susan Herrmann; Elizabeth McKinnon; Cecily Metcalf; Bruce Latham; Simon Mallal
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

Review 2.  Drug transporter pharmacogenetics in nucleoside-based therapies.

Authors:  Ekaitz Errasti-Murugarren; Marçal Pastor-Anglada
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

Review 3.  Metabolism of Zidovudine.

Authors:  G J Veal; D J Back
Journal:  Gen Pharmacol       Date:  1995-11

Review 4.  Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?

Authors:  Anne Maagaard; Dag Kvale
Journal:  J Antimicrob Chemother       Date:  2009-09-09       Impact factor: 5.790

5.  Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1).

Authors:  Pedro Cano-Soldado; Ignacio M Lorráyoz; Míriam Molina-Arcas; F Javier Casado; Javier Martinez-Picado; M Pilar Lostao; Marçal Pastor-Anglada
Journal:  Antivir Ther       Date:  2004-12

6.  Zidovudine and Lamivudine for HIV Infection.

Authors:  Peter L Anderson; Joseph E Rower
Journal:  Clin Med Rev Ther       Date:  2010

7.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Authors:  Hélène C F Côté; Zabrina L Brumme; Kevin J P Craib; Christopher S Alexander; Brian Wynhoven; Lillian Ting; Hubert Wong; Marianne Harris; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

8.  The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes.

Authors:  Omar Janneh; Andrew Owen; Patrick G Bray; David J Back; Munir Pirmohamed
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

9.  MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.

Authors:  Mark Eilers; Upal Roy; Debasis Mondal
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

10.  The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine.

Authors:  V A Eagling; J L Howe; M J Barry; D J Back
Journal:  Biochem Pharmacol       Date:  1994-07-19       Impact factor: 5.858
View more
  4 in total

1.  Rapid, user-friendly, and inexpensive detection of azidothymidine.

Authors:  Ying Luo; Tianwei Jia; Jieqiong Fang; Dandan Liu; Varma Saikam; Xiaolin Sheng; Suri S Iyer
Journal:  Anal Bioanal Chem       Date:  2021-01-23       Impact factor: 4.142

Review 2.  Individualization of antiretroviral therapy--pharmacogenomic aspect.

Authors:  Bhavik Dalal; Aruna Shankarkumar; K Ghosh
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

Review 3.  Antiviral Effects of Plant-Derived Essential Oils and Their Components: An Updated Review.

Authors:  Li Ma; Lei Yao
Journal:  Molecules       Date:  2020-06-05       Impact factor: 4.411

Review 4.  Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics.

Authors:  Ran Chen; Tingting Wang; Jie Song; Daojun Pu; Dan He; Jianjun Li; Jie Yang; Kailing Li; Cailing Zhong; Jingqing Zhang
Journal:  Int J Nanomedicine       Date:  2021-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.